Published in Virology on April 06, 2007
Papillomaviruses: Viral evolution, cancer and evolutionary medicine. Evol Med Public Health (2015) 1.13
Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol (2008) 0.81
Analysis of the long control region of bovine papillomavirus type 1 associated with sarcoids in equine hosts indicates multiple cross-species transmission events and phylogeographical structure. J Gen Virol (2014) 0.77
TRANSMISSION TO RODENTS OF LANSING TYPE POLIOMYELITIS VIRUS ORIGINATING IN THE MIDDLE EAST. Science (1943) 4.57
Sequence of the structural gene for xanthine dehydrogenase (rosy locus) in Drosophila melanogaster. Genetics (1987) 2.23
Conservation of cytoplasmic poly (A)-containing RNA in mouse and rat. Nature (1975) 2.18
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology (1996) 2.08
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology (1991) 1.70
Transcriptional control signals in the genome of bovine papillomavirus type 1. Nature (1983) 1.70
Age-restricted cervical screening: HPV testing at age 50 identifies a high risk group for cervical disease. Int J Gynecol Cancer (2002) 1.55
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology (1995) 1.48
INDUCED RESISTANCE OF THE CENTRAL NERVOUS SYSTEM TO EXPERIMENTAL INFECTION WITH EQUINE ENCEPHALOMYELITIS VIRUS : II. SEROTHERAPY IN WESTERN VIRUS INFECTION. J Exp Med (1943) 1.39
Persistence of non-integrated viral DNA in bovine cells transformed in vitro by bovine papillomavirus type 2. Nature (1981) 1.35
Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. J Gen Virol (1996) 1.32
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Tandem integration of complete and defective SV40 genomes in mouse-human somatic cell hybrids. Cell (1978) 1.24
Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol (2001) 1.23
Two classes of messenger RNA in cultured rat cells: repetitive sequence transcripts and unique sequence transcripts. J Mol Biol (1974) 1.16
Parental attitudes and information needs in an adolescent HPV vaccination programme. Br J Cancer (2008) 1.15
Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination. Vet Rec (1990) 1.15
Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation. Proc Natl Acad Sci U S A (1992) 1.15
Unintegrated viral DNA sequences in a hamster tumor induced by bovine papilloma virus. J Virol (1981) 1.14
Molecular heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses. Virology (1981) 1.13
Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet Rec (1990) 1.11
Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol (2002) 1.10
alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. J Gen Virol (2000) 1.09
Histopathological changes produced in rabbits by experimental inoculation with hemolytic streptococci, certain of their component factors and saponin: A preliminary report. Am J Pathol (1940) 1.07
Association of bovine papillomavirus with the equine sarcoid. J Gen Virol (2003) 1.07
The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Mol Carcinog (1991) 1.06
Lithium used with a diuretic. Br Med J (1977) 1.04
Aberrant expression of TopBP1 in breast cancer. Histopathology (2007) 1.01
Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. J Gen Virol (1990) 1.01
DNA-RNA hybridization. Philos Trans R Soc Lond B Biol Sci (1975) 0.99
Sodium influx blockade and hypoxic damage to CA1 pyramidal neurons in rat hippocampal slices. J Neurophysiol (2001) 0.99
The nucleotide sequence and genome organization of bovine papillomavirus type 4. J Gen Virol (1987) 0.99
Molecular cloning and characterization of human papillomavirus type 7 DNA. Virology (1986) 0.98
Single walled carbon nanotubes induce indirect cytotoxicity by medium depletion in A549 lung cells. Toxicol Lett (2008) 0.98
Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res (2006) 0.98
A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. Virology (1984) 0.98
The in vitro effects of piroxicam and meloxicam on canine cell lines. J Small Anim Pract (2006) 0.97
Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours. Oncogene (2006) 0.96
The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J Virol (1996) 0.95
Mode of stimulation by adenosine 3':5'-cyclic monophosphate of the sodium efflux in barnacle muscle fibres. J Physiol (1976) 0.93
Repetitious and unique sequences in the heterogeneous nuclear and cytoplasmic messenger RNA of mammalian and insect cells. Cell (1974) 0.92
Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region. J Virol (1995) 0.92
Role of different sponge cell types in species specific cell aggregation. Nat New Biol (1971) 0.91
Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology (2008) 0.89
Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. J Viral Hepat (2009) 0.89
The importance of sodium for anoxic transmission damage in rat hippocampal slices: mechanisms of protection by lidocaine. J Physiol (1995) 0.88
The effect of blocking sodium influx on anoxic damage in the rat hippocampal slice. Neuroscience (1989) 0.88
Equine telomeres and telomerase in cellular immortalisation and ageing. Mech Ageing Dev (2003) 0.88
DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland. Br Med J (Clin Res Ed) (1986) 0.87
The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. J Virol (1995) 0.87
Molecularly cloned bovine papillomavirus DNA transforms mouse fibroblasts in vitro. J Gen Virol (1983) 0.86
Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol (1991) 0.86
The biology of papillomaviruses and their role in oncogenesis. Anticancer Res (1985) 0.86
Biosynthesis and distribution of ribosomal particles in the cellular slime mould, Dictyostelium purpureum. J Mol Biol (1970) 0.85
Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. J Gen Virol (1991) 0.85
Automated repetitive microsampling of blood: growth hormone profiles in conscious male rats. J Endocrinol (1986) 0.85
E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase. J Gen Virol (2001) 0.85
Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res (2003) 0.85
Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol (1996) 0.85
Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol (2009) 0.84
Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity. Mol Carcinog (1993) 0.84
Molecular cloning of bovine papillomavirus genomes and comparison of their sequence homologies by heteroduplex mapping. J Gen Virol (1982) 0.84
Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks. Vet Comp Oncol (2009) 0.83
Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay. J Clin Virol (2004) 0.83
Analysis of the transforming functions of bovine papillomavirus type 4. Virology (1993) 0.83
A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein. J Virol (2001) 0.83
16(th) IHIW: analysis of HLA population data, with updated results for 1996 to 2012 workshop data (AHPD project report). Int J Immunogenet (2012) 0.82
Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. J Gen Virol (1990) 0.82
Management of obstructive sleep apnea: comparison of various treatment modalities. Laryngoscope (1988) 0.82
Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. J Gen Virol (2008) 0.82
Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection. Cancer Immunol Immunother (2001) 0.82
Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Virus Res (2005) 0.82
Extensive papillomatosis of the bovine upper gastrointestinal tract. J Comp Pathol (2003) 0.82
Pneumothorax, mechanical ventilation, and periventricular haemorrhage. Lancet (1981) 0.82
Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol (2008) 0.81
Ribosomal subunits in Dictyostelium discoideum. The effect of an ionic detergent and a nonionic detergent. Biochim Biophys Acta (1969) 0.81
Thiopental attenuates hypoxic changes of electrophysiology, biochemistry, and morphology in rat hippocampal slice CA1 pyramidal cells. Stroke (1999) 0.81
An enhanced epithelial response of a papillomavirus promoter to transcriptional activators. J Biol Chem (1999) 0.81
Linear B-cell epitopes in the N-terminus of L2 of bovine papillomavirus type 4. Res Vet Sci (1997) 0.81
Midazolam improves electrophysiologic recovery after anoxia and reduces the changes in ATP levels and calcium influx during anoxia in the rat hippocampal slice. Anesthesiology (1991) 0.81
Bovine papillomavirus type 4 in oesophageal papillomas of cattle from the south of Italy. J Comp Pathol (2003) 0.81
Bovine papillomavirus type 1 DNA and E5 oncoprotein expression in water buffalo fibropapillomas. Vet Pathol (2009) 0.81
Multiple Harvey-ras genes in the bovine genome. Oncogene (1989) 0.80
c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic. Oncogene (1992) 0.80
Cooperation between papillomavirus and chemical cofactors in oncogenesis. Crit Rev Oncog (1993) 0.80
Papillomavirus infection in cattle: viral and chemical cofactors in naturally occurring and experimentally induced tumours. Ciba Found Symp (1986) 0.80
Mapping of two novel transcripts of bovine papillomavirus type 4. J Gen Virol (1988) 0.79
Differential fall in ATP accounts for effects of temperature on hypoxic damage in rat hippocampal slices. J Neurophysiol (2000) 0.79
T cell responses to BPV-4 E7 during infection and mapping of T cell epitopes. Virology (1995) 0.79
Malignant transformation of a papilloma induced by bovine papillomavirus type 4 in the nude mouse renal capsule. J Gen Virol (1991) 0.79
Generation of native bovine mAbs by phage display. Proc Natl Acad Sci U S A (1999) 0.79